Every year the Cure Alzheimerās Fund (CAF) Research Consortium members get together with the Board of Directors to discuss their respective research projects, refine their strategy, and leave with a clear mission. This year was no exception. On Feb. 5, 30 individuals gathered in San Diego for a full day of ...
April 21, 2015
For several years now, researchers have been aware of important links between cholesterol and Alzheimer’s disease. A new study by Dr. Dora Kovacs and her team at Massachusetts General Hospital brings us one step closer to a potential drug that could interrupt the disease process. Previous studies have shown that cholesterol ...
July 29, 2013
Research uncovering 12 new gene variations connected to the cause of the early-onset familial form of Alzheimerās disease (EO-FAD), which generally strikes before the age of 65, is being published in the journal Molecular Psychiatry. The Cure Alzheimerās Fund-supported research conducted a comprehensive genome-wide screen of over 100 EO-FAD families, identifying ...
June 18, 2013
The goal of this project is to determine which types of cells and factors in the brain influence excess Abeta deposition in Alzheimerās patients, using animal models of the disease. Alzheimerās disease (AD) is a progressive neurodegenerative disease characterized by impairments in memory and cognition, neuronal loss and deposition of Abeta ...
February 11, 2011
On Friday, August 24, Eli Lilly announced that their beta-amyloid immunotherapy (solanezumab) failed to meet its primary clinical endpoints for Alzheimer’s disease. This disappointment follows the recent failure of another promising beta-amyloid immunotherapy, bapineuzumab from Pfizer/Johnson and Johnson-Jannsen/Elan. Both drugs failed in Phase 3 clinical trials, where they were being ...
August 27, 2012
Dear Friends, Ā For many years, Alzheimerās disease research was stuck, and we set out to get it unstuck. Ā The drug pipeline was coming up dry, and researchers werenāt encouraged to think big or bold. Even the most prominent Alzheimerās scientists were spending a third of their time filling out lengthy grant applications. ...
December 20, 2011
Cure Alzheimer’s Fund co-founder and venture capitalist Henry McCance and Dr. Rudolph Tanzi discuss the latest research on Alzheimer’s, the hope of discovering a cure by 2020 and the success of using a venture capital funding model to spur on research at TEDMED 2010. Alzheimer’s Reading Room, a leading source of ...
July 7, 2011
Crediting his mom’s strength in her battle against Alzheimer’s as an inspiration, Alan Arnette reflects on how he overcame the mental and physical demands of his climb up and down Mt. Everest. In his latest blog Alan talks about how he found the strength to make it to the summit and ...
May 26, 2011
CNN will be airing the Larry King special āUnthinkable: the Alzheimerās Epidemicā on Sunday, May 1 at 8:00 PM in most time zones. King will explore Alzheimerās disease, the people it affects, its impact on their families, the latest in treatment, and why it is critical to find a cure ...
April 25, 2011
We note with great sorrow the passing of Sargent Shriver.Ā Another victim of Alzheimerās disease. Shriver and his family have made tremendous contributions to American society through the Peace Corps, Special Olympics and so many other positive initiatives to affect the lives of people left out, left behind or disenfranchised in ...
January 19, 2011
